Verona Pharma PLC (VRNA)
13.00
-0.36
(-2.69%)
USD |
NASDAQ |
May 17, 16:00
13.03
+0.03
(+0.23%)
After-Hours: 20:00
Verona Pharma Shareholders Equity (Quarterly): 224.99M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 224.99M |
December 31, 2023 | 249.28M |
September 30, 2023 | 263.53M |
June 30, 2023 | 273.09M |
March 31, 2023 | 276.75M |
December 31, 2022 | 230.47M |
September 30, 2022 | 237.48M |
June 30, 2022 | 110.88M |
March 31, 2022 | 126.31M |
December 31, 2021 | 148.00M |
September 30, 2021 | 168.20M |
June 30, 2021 | 154.40M |
March 31, 2021 | 172.41M |
December 31, 2020 | 184.85M |
September 30, 2020 | 197.72M |
June 30, 2020 | 23.62M |
March 31, 2020 | 31.94M |
December 31, 2019 | 42.74M |
September 30, 2019 | 49.52M |
June 30, 2019 | 63.14M |
March 31, 2019 | 75.80M |
December 31, 2018 | 80.47M |
September 30, 2018 | 84.95M |
June 30, 2018 | 87.35M |
March 31, 2018 | 92.01M |
Date | Value |
---|---|
December 31, 2017 | 107.95M |
September 30, 2017 | 114.17M |
June 30, 2017 | 121.23M |
December 31, 2016 | 42.53M |
June 30, 2016 | 5.562M |
June 30, 2016 | 5.562M |
December 31, 2015 | 8.050M |
June 30, 2015 | 14.43M |
June 30, 2015 | 14.43M |
December 31, 2014 | 19.62M |
June 30, 2014 | 23.60M |
June 30, 2014 | 23.60M |
December 31, 2013 | 3.410M |
June 30, 2013 | 3.994M |
June 30, 2013 | 3.994M |
December 31, 2012 | 4.207M |
June 30, 2012 | 6.336M |
June 30, 2012 | 6.336M |
December 31, 2011 | 6.289M |
June 30, 2011 | 4.242M |
December 31, 2010 | 5.326M |
June 30, 2010 | 6.765M |
December 31, 2009 | 7.247M |
June 30, 2009 | 5.322M |
December 31, 2008 | 5.849M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
23.62M
Minimum
Jun 2020
276.75M
Maximum
Mar 2023
161.47M
Average
170.31M
Median
Shareholders Equity (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | 5.959M |
NuCana PLC | 18.96M |
TC BioPharm (Holdings) PLC | 3.421M |
Bicycle Therapeutics PLC | 356.05M |
Adaptimmune Therapeutics PLC | 24.38M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 289.91M |
Total Liabilities (Quarterly) | 64.92M |